Blood transfusion and adjunctive therapy in the bleeding trauma patient;Transfusion du traumatisé grave et méthodes d'épargne

Transfusion Clinique et Biologique

Volumn 15, Issue 5, 2008, Pages 240-245

  Ozier, Y ^a  

^a AP HP université Paris Descartes ^*  (France)

Author keywords

Adjunctive therapy; Hemorrhage; Trauma patient

Indexed keywords

BLOOD CLOTTING FACTOR; HEMOGLOBIN;

ACIDOSIS; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; COLLOID; CORRELATION ANALYSIS; CRYSTALLOID; DILUTION; ELECTIVE SURGERY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HEMODILUTION; HEMOSTASIS; HOSPITAL ADMISSION; HOSPITAL MANAGEMENT; HUMAN; HYPOTHERMIA; IN VIVO STUDY; LABORATORY TEST; MATHEMATICS; MEDICAL LITERATURE; PRACTICE GUIDELINE; SHOCK; THROMBOCYTE; THROMBOCYTE COUNT; TISSUE OXYGENATION; TRAUMATIC BRAIN INJURY;

ADULT; BLOOD COAGULATION FACTORS; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; DISSEMINATED INTRAVASCULAR COAGULATION; EMERGENCIES; FLUID THERAPY; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HUMANS; HYPOVOLEMIA; PLASMA; PRACTICE GUIDELINES AS TOPIC; WOUNDS AND INJURIES;

EID: 54949158678     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2008.09.010     Document Type: Article

References (33)

1. Spahn D.R., Cerny V., Coats T.J., et al. Management of bleeding following major trauma: a European guideline. Crit Care 11 (2007) R17
2. Afssaps. Recommandations pour la pratique clinique. Transfusion de globules rouges homologues : Produits, indications, alternatives. 2002.
3. Hardy J.F., de Moerloose P., and Samama C.M. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 53 (2006) S40-S58
4. Cosgriff N., Moore E.E., Sauaia A., et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma 42 (1997) 857-861
5. Hiippala S.T., Myllylä G.J., and Vahtera E.M. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81 (1995) 360-365
6. McLoughlin T.M., Fontana J.L., Alving B., Mongan P.D., and Bunger R. Profound normovolemic hemodilution: hemostatic effects in patients and in a porcine model. Anesth Analg 83 (1996) 459-465
7. Collins J.A. Problems associated with the massive transfusion of stored blood. Surgery 75 (1974) 274-295
8. Hirshberg A., Dugas M., Banez E.I., et al. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 54 (2003) 454-463
9. Ketchum L., Hess J.R., and Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 60 (2006) S51-S58
10. Wolberg A.S., Meng Z.H., Monroe III D.M., and Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 56 (2004) 1221-1228
11. Meng Z.H., Wolberg A.S., Monroe III D.M., and Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 55 (2003) 886-891
12. Egli G.A., Zollinger A., Seifert B., et al. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 78 (1997) 684-689
13. Mardel S.N., Saunders F.M., Allen H., et al. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 80 (1998) 204-207
14. Innerhofer P., Fries D., Margreiter J., et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 95 (2002) 858-865
15. Kozek-Langenecker S.A. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103 (2005) 654-660
16. Afssaps. Recommandations pour la pratique clinique. Transfusion de plasma frais congelé : Produits, indications. 2002.
17. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105:198-208.
18. Stainsby D., MacLennan S., Thomas D., Isaac J., and Hamilton P.J. Guidelines on the management of massive blood loss. Br J Haematol 135 (2006) 634-641
19. Brohi K., Singh J., Heron M., and Coats T. Acute traumatic coagulopathy. J Trauma 54 (2003) 1127-1130
20. MacLeod J.B., Lynn M., McKenney M.G., Cohn S.M., and Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 55 (2003) 39-44
21. Maegele M., Lefering R., Yucel N., et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 38 (2007) 298-304
22. Ho A.M., Dion P.W., Cheng C.A., et al. A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg 48 (2005) 470-478
23. Gonzalez E.A., Moore F.A., Holcomb J.B., et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 62 (2007) 112-119
24. Borgman M.A., Spinella P.C., Perkins J., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a Combat Support Hospital. J Trauma 63 (2007) 805-813
25. Hess J.R., Dutton R.B., Holcomb J., and Scalea T.M. Giving plasma at a 1:1 ratio with red cells in resuscitation: who might benefit?. Transfusion 48 (2008) 1763-1765
26. Rugeri L., Levrat A., David J.S., et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 5 (2007) 289-295
27. Fries D., Innerhofer P., Reif C., et al. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg 102 (2006) 347-351
28. Fries D., Krismer A., Klingler A., et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 95 (2005) 172-177
29. Fenger-Eriksen C., Anker-Moller E., Heslop J., Ingerslev J., and Sorensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 94 (2005) 324-329
30. De Lorenzo C., Calatzis A., Welsch U., and Heindl B. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 102 (2006) 1194-1200
31. Chowdhury P., Saayman A.G., Paulus U., Findlay G.P., and Collins P.W. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125 (2004) 69-73
32. Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 (2005) 8-15
33. Vincent J.L., Rossaint R., Riou B., et al. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective. Crit Care 10 (2006) R120